Internal medicine

Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community

Retrieved on: 
Tuesday, February 27, 2024
Gynaecology, Culture, Blood, Urology, Gastroenterology, CRC, FIT, Internal medicine, The German, Practitioner, Congress, Colorectal cancer, DNA, Cancer, Pharmaceutical industry

This data underscores the significant impact gynecologists have in the early detection and prevention efforts against CRC.

Key Points: 
  • This data underscores the significant impact gynecologists have in the early detection and prevention efforts against CRC.
  • The Gynecology Congress is a premier event dedicated to gynecological health, offering Mainz Biomed an invaluable opportunity to connect with these vital healthcare providers.
  • This effort is aimed at increasing brand awareness and establishing ColoAlert® as a key component in medical practices for CRC screening.
  • In the coming months, Mainz Biomed will continue to actively participate in medical conferences that cater to its key demographic.

National Study Finds AI Use in Healthcare Delivery Hampered by Trust, Training and Liability Fears

Retrieved on: 
Monday, February 26, 2024
Algorithm, Internal medicine, Digital, AI, Gen, Physician, Health, Generative, Public health, Cardiology, Providers, ChatGPT, Risk, Oncology, Synthetic media, LLM, Patient, Optimism, Policy, Primary care, Clinician, Trust, Medical device

More than half believe AI can save them time (57%) and that it will transform healthcare delivery (56%), while exactly half (50%) believe AI use can help them deliver better patient care.

Key Points: 
  • More than half believe AI can save them time (57%) and that it will transform healthcare delivery (56%), while exactly half (50%) believe AI use can help them deliver better patient care.
  • Yet despite high levels of personal use and optimism for its future impact in healthcare, clinicians remain wary of using AI for healthcare in the near term.
  • And they don’t trust that AI will reduce liability: 4 in 10 believe that AI use will put them at greater risk of liability.
  • Training: Nearly half (42%) of clinicians are unprepared for implementation of Gen AI into their practice but 50% agree that implementation will require new training.

BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment

Retrieved on: 
Friday, February 23, 2024
Incidence, AAAAI, Pharmacy, Attack, Expert network, Tranexamic acid, Prior, Effectiveness, Pharmacist, Washington Convention Center, University, Conditional sentence, Day, Lanadelumab, Safety, Androgen, HAE, History, Hereditary angioedema, Tolerability, Monitoring, Internal medicine, Walter, BioCryst Pharmaceuticals, Medicine, Disease, Ageing, Observational study, Poster, American Academy, Pharmaceutical industry

“These additional analyses of real-world use of ORLADEYO show that any person living with HAE has the potential to experience a rapid, substantial and sustained reduction in their monthly attack rate with ORLADEYO.

Key Points: 
  • “These additional analyses of real-world use of ORLADEYO show that any person living with HAE has the potential to experience a rapid, substantial and sustained reduction in their monthly attack rate with ORLADEYO.
  • These analyses present the overall attack rate progression and attack rate progression stratified by severity (i.e., number of attacks at baseline), prior prophylaxis and C1-INH level and function.
  • These findings further demonstrate that ORLADEYO can help maintain disease control in patients with lower baseline attack rates and further reduce attack rates in patients with more active disease.
  • Berotralstat Prophylaxis Reduces HAE Attack Rates Regardless of Baseline Attacks: Real-World Outcomes; Poster #012; Friday, February 23, 3:15-4:15 p.m.

Dr. Melody Rodarte: Breaking Barriers and Transforming Healthcare in Arizona - Wins Phoenix Magazine TOP DOC for Sixth Year

Retrieved on: 
Friday, March 8, 2024
General Health, Fitness & Nutrition, Health, Other Health, The, Multimedia, Dream, Weight loss, Female, Empowerment, Internal medicine, Wellness, Internal, Obesity medicine, Face, Nursing

However, behind this impressive achievement lies a journey marked by perseverance, resilience, and a steadfast commitment to shatter stereotypes.

Key Points: 
  • However, behind this impressive achievement lies a journey marked by perseverance, resilience, and a steadfast commitment to shatter stereotypes.
  • View the full release here: https://www.businesswire.com/news/home/20240308041333/en/
    Reflecting on her path to success, Dr. Rodarte recalls facing skepticism and doubt, particularly as a female, first-generation college-bound student and ethnic minority.
  • "Words are powerful," Dr. Rodarte emphasizes, underscoring the importance of self-belief and resilience in the face of adversity.
  • From weight loss and nutrition to internal medicine and aesthetics, every aspect of patient well-being is meticulously considered and addressed.

Access TeleCare and UT Southwestern Project Aims to Improve Outcomes for Rural Patients with Heart Failure

Retrieved on: 
Wednesday, March 6, 2024
Research, Hospitals, Health Technology, Telemedicine, Virtual Medicine, Cardiology, Managed Care, General Health, Health, Science, Other Science, Chest pain, Bangladesh Technical Education Board, American Heart Association, Telehealth, AHA, Stroke, MHealth, Heart failure, American Heart, Telecare, Arrhythmia, Internal medicine, Associate, Cardiac rehabilitation, Patient, Hospital

Access TeleCare and the UT Southwestern Medical Center, with integral support from the American Heart Association (AHA), are leading a two-year project to evaluate options to improve the care of patients with heart failure in rural communities across the country.

Key Points: 
  • Access TeleCare and the UT Southwestern Medical Center, with integral support from the American Heart Association (AHA), are leading a two-year project to evaluate options to improve the care of patients with heart failure in rural communities across the country.
  • Create a registry of 1,000 rural patients with heart failure who are hospitalized in rural hospitals that have a teleCardiology program to document patterns of care.
  • “Access TeleCare has long been a pioneer in eliminating barriers to timely specialty care in rural communities by bringing specialists to patients through the power of telemedicine,” said Chris Gallagher, M.D., CEO, Access TeleCare.
  • These programs give hospitals 24/7 access to cardiologists for patients hospitalized with heart failure, arrhythmias, chest pain, and other heart-related conditions.

KaliVir Immunotherapeutics Appoints James M. Burke, M.D., as Chief Medical Officer

Retrieved on: 
Wednesday, February 21, 2024
Biotechnology, Pharmaceutical, Health, Oncology, Therapy, CMO, Potyvirus, Immunotherapy, Hematology, Growth, GM, AKA, Bladder cancer, Patient, Internal medicine, AAV, Lentivirus, Pharmaceutical industry

KaliVir Immunotherapeutics, Inc. , a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced the appointment of industry leader James M. Burke, M.D., as Chief Medical Officer (CMO) to further advance its vision of providing patients with truly life changing cancer therapeutics by leveraging its next generation oncolytic virus platform.

Key Points: 
  • KaliVir Immunotherapeutics, Inc. , a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced the appointment of industry leader James M. Burke, M.D., as Chief Medical Officer (CMO) to further advance its vision of providing patients with truly life changing cancer therapeutics by leveraging its next generation oncolytic virus platform.
  • Dr. Burke brings over 20 years of global development experience in immuno-oncology.
  • “We are thrilled to welcome Dr. Burke to our team as we bring our pipeline of multi-mechanistic oncolytic virus programs into the clinic,” said Helena Chaye, Ph.D., J.D., Chief Executive Officer of KaliVir.
  • Previously, Dr. Burke was Chief Medical Office at Sillajen, Jennerex and Turnstone Biologics.

Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting

Retrieved on: 
Tuesday, February 20, 2024
Health, Infectious Diseases, Other Health, General Health, Pharmaceutical, Biotechnology, Annual general meeting, Convention center, Allergy, Asthma, AAAAI, University, Therapy, Internal medicine, Level 2, American Academy, Pharmaceutical industry

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present final STAR-0215 Phase 1a healthy subject data at the upcoming American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting in Washington, D.C. on February 23, 2024 at 3:15pm EST.

Key Points: 
  • Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present final STAR-0215 Phase 1a healthy subject data at the upcoming American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting in Washington, D.C. on February 23, 2024 at 3:15pm EST.
  • Dr. William Lumry, M.D., Clinical Professor of Internal Medicine at the University of Texas Health Science Center at Dallas, will present a poster titled, “Updated Results from a Phase 1a Trial of STAR-0215 for Hereditary Angioedema” at 3:15pm EST in the Convention Center, Level 2, Hall D, poster number 032.

"Double Life" of Key Immune Protein Reveals New Strategies for Treating Cancer and Autoimmune Diseases

Retrieved on: 
Friday, March 8, 2024
Bangladesh Technical Education Board, University of Oslo, Cancer, University, The central science, Immune system, Research, Doctor of Philosophy, Science Immunology, National Institutes of Health, MD, Moses Austin, Neoplasm, Inflammation, Wang, Wellcome Trust, Rheumatology, Lupus, PD-1, Bristol Myers Squibb, Howard Hughes Medical Institute, Biochemistry, NYU, Autoimmunity, Perlmutter, Rheumatoid arthritis, Pathology, Ligand, Pharmacology, NYU Langone Health, Patient, Hanmi Pharmaceutical, Internal medicine, Biomedical sciences, Funding of science, Columbia University, Mouse, Vaccine

The same findings also support experimental treatment strategies for autoimmune diseases, in which the immune system attacks the body, because stimulating the action of PD-1, as opposed to restricting it, can potentially block an overactive immune response.

Key Points: 
  • The same findings also support experimental treatment strategies for autoimmune diseases, in which the immune system attacks the body, because stimulating the action of PD-1, as opposed to restricting it, can potentially block an overactive immune response.
  • The study results revolve around the body's immune system, which is primed to attack virally infected and cancerous cells while leaving normal cells alone.
  • The immune system recognizes tumors as abnormal, but cancer cells can hijack checkpoints to turn off immune responses.
  • At the same time, PD-1 signaling is slowed in autoimmune diseases like rheumatoid arthritis, lupus, and type 1 diabetes, such that the action of unchecked immune cells creates inflammation that can damage tissues.

The Inner Circle acknowledges Amir A. Rasheed as a Distinguished Healthcare Professional

Retrieved on: 
Thursday, March 7, 2024
Houston Methodist West Hospital, Inner circle, Iron-deficiency anemia, Multimedia, Houston Methodist Baytown Hospital, Hematology, Blood, North Shore University Hospital, Dow Medical College, SUNY Downstate Medical Center, St Luke's, State university system, Prognosis, Haemophilia, Internal medicine, Leukemia, Patient, Oncology, Medicine, Multiple myeloma, Medical Center, Diagnosis, Anti-transglutaminase antibodies, Lymphoma, Cancer, Hospital

SUGARLAND, Texas, March 7, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Amir A. Rasheed is acknowledged as a Distinguished Healthcare Professional for his contributions to the fields of Oncology and Hematology.

Key Points: 
  • SUGARLAND, Texas, March 7, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Amir A. Rasheed is acknowledged as a Distinguished Healthcare Professional for his contributions to the fields of Oncology and Hematology.
  • Dr. Rasheed pursued his medical education at Dow Medical College where he earned a medical degree.
  • He then relocated to the United States to complete a residency in internal medicine at the State University of New York Health Science Center at Brooklyn.
  • Known for his compassionate care and clinical excellence, Dr. Rasheed has dedicated his life to delivering the highest standard of quality care to his patients.

DocNow Raises Seed Round to Further Expand Next Generation Electronic Health Record (EHR) System for Post-Acute Care Providers

Retrieved on: 
Thursday, March 7, 2024
Mental health, History, EHR, Cardiology, Physical medicine and rehabilitation, Electronic health record, Internal medicine, Waterline, Patient, Automation, Psychiatry, Rehabilitation, Nursing

BELLEVUE, Wash., March 7, 2024 /PRNewswire/ -- DocNow , a provider of Electronic Health Record (EHR) and wound care management solutions for Post-Acute Care providers, today announced it has closed a Series Seed round led by Waterline Ventures .

Key Points: 
  • BELLEVUE, Wash., March 7, 2024 /PRNewswire/ -- DocNow , a provider of Electronic Health Record (EHR) and wound care management solutions for Post-Acute Care providers, today announced it has closed a Series Seed round led by Waterline Ventures .
  • DocNow was designed by a physician who was frustrated with the inefficiencies of legacy Post-Acute Care systems.
  • DocNow services several specialties including Physical Medicine and Rehabilitation, Cardiology / Pulmonology, Behavioral Health (Psychiatry + Psychology), and Internal Medicine.
  • DocNow offers assistive note generation, advanced templating, and multiple other tools to help providers efficiently complete their work.